Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Hey, Paul, Here is the link to the Naz Capital

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 238)
Posted On: 11/21/2019 11:30:55 PM
Posted By: Buildit
Re: Paul Jackson #8789
Hey, Paul,

Here is the link to the Naz Capital Mkt listing requirements:

http://nasdaq.cchwallstreet.com/nasdaq/main/n...efault.asp

From that, here is the excerpt for the $3 (right after the $4 bid price):

" B) Minimum closing price of $3 per share, if the Company meets the requirements of the Equity or Net Income Standards under Rules 5505(b)(1) or (b)(3)"

Of note, we already meet the Equity Standard, and the Net Tangible Assets requirement is not a part of the $3 listing... hooray!

Also of note, for what it's worth, I have no expectation that we will qualify for the Naz in the next few months UNLESS the NGIO spin is highly successful (big $, Naz NGIO listing). I am a little skeptical of that as well, as it's not just the hope of great things that brings this to fruition... it's someone with deep pockets spending big money because they believe it is actually worth something. (Come on, MRK!)

I honestly think we will likely be in this situation until there is organic growth on the Ks... maybe 2-3 more to see a trend and some sort of real revenue growth.

Of course, there doesn't need to be much in the way of revenues to support the current pricing, just the visibility to covering cost and any sort of profit potential on the horizon will do the trick. Using my simplified model that you all know and love:

Say the price gets cut in half to $0.465 and merits a 15X multiple.
That's an implied NI of $.031.
On ~70MM shares , that's an ANNUAL PROFIT of $2.17MM or $542,500 of profit per quarter.

So again I say, this company either folds or blows the current expectations out of the water.

Bring on the CC!


(0)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us